WO2001064834A8 - Nouveaux acides nucleiques et polypeptides - Google Patents
Nouveaux acides nucleiques et polypeptidesInfo
- Publication number
- WO2001064834A8 WO2001064834A8 PCT/US2001/004926 US0104926W WO0164834A8 WO 2001064834 A8 WO2001064834 A8 WO 2001064834A8 US 0104926 W US0104926 W US 0104926W WO 0164834 A8 WO0164834 A8 WO 0164834A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acids
- polypeptides
- novel nucleic
- new
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01912764A EP1276751A4 (fr) | 2000-02-28 | 2001-02-26 | Nouveaux acides nucleiques et polypeptides |
CA002401505A CA2401505A1 (fr) | 2000-02-28 | 2001-02-26 | Nouveaux acides nucleiques et polypeptides |
US10/220,335 US20050175607A1 (en) | 2000-02-28 | 2001-02-26 | Novel nucleic acids and polypeptides |
AU2001241511A AU2001241511A1 (en) | 2000-02-28 | 2001-02-26 | Novel nucleic acids and polypeptides |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51512600A | 2000-02-28 | 2000-02-28 | |
US09/515,126 | 2000-02-28 | ||
US57740900A | 2000-05-18 | 2000-05-18 | |
US09/577,409 | 2000-05-18 | ||
US59770700A | 2000-06-17 | 2000-06-17 | |
US09/597,707 | 2000-06-17 | ||
US61680700A | 2000-07-14 | 2000-07-14 | |
US09/616,807 | 2000-07-14 | ||
US66464100A | 2000-09-19 | 2000-09-19 | |
US09/664,641 | 2000-09-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001064834A2 WO2001064834A2 (fr) | 2001-09-07 |
WO2001064834A8 true WO2001064834A8 (fr) | 2002-02-14 |
Family
ID=27541818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/004926 WO2001064834A2 (fr) | 2000-02-28 | 2001-02-26 | Nouveaux acides nucleiques et polypeptides |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1276751A4 (fr) |
AU (1) | AU2001241511A1 (fr) |
CA (1) | CA2401505A1 (fr) |
WO (1) | WO2001064834A2 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6706262B1 (en) | 1998-03-18 | 2004-03-16 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
MXPA01013425A (es) * | 1999-06-29 | 2003-09-04 | Autogen Res Pty Ltd | Genes novedosos y su uso en la modulacion de la obesidad, diabetes y desequilibrio de la energia. |
CA2401438C (fr) * | 2000-02-29 | 2011-11-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques |
US7235649B2 (en) | 2000-03-24 | 2007-06-26 | Duke University | Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same |
AU2001247759A1 (en) | 2000-03-24 | 2001-10-08 | Duke University | Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
WO2001090321A2 (fr) * | 2000-05-19 | 2001-11-29 | Millennium Pharmaceuticals, Inc. | 55158, une nouvelle anhydrase carbonique humaine et son utilisation |
US20040210042A1 (en) * | 2001-07-19 | 2004-10-21 | Tsuchida Jun-Ichi | Polypeptides relating to signal transfer of advanced glycation end product receptor |
JP4265402B2 (ja) | 2001-09-25 | 2009-05-20 | ソニー株式会社 | p300ヒストンアセチル化酵素インヒビターを含む転写阻害用組成物及び該p300ヒストンアセチル化酵素インヒビターを阻害し得る阻害物質のスクリーニング方法 |
AU2002356959A1 (en) * | 2001-11-16 | 2003-06-10 | Incyte Genomics, Inc. | Organelle-associated proteins |
WO2003045990A2 (fr) * | 2001-11-26 | 2003-06-05 | Hybrigenics | Interactions proteine-proteine impliquant une signalisation du facteur de croissance transformant $g(b) ou des signaux de transduction d'elements de la famille des facteurs transformants $g(b) |
EP1487998B1 (fr) * | 2002-03-20 | 2007-06-06 | Novartis AG | Methode pour diagnostiquer et traiter la schizophrenie |
GB0217033D0 (en) * | 2002-07-23 | 2002-08-28 | Delta Biotechnology Ltd | Gene and polypeptide sequences |
KR101083852B1 (ko) | 2002-07-25 | 2011-11-15 | 소니 주식회사 | 유전자 전사 조절제 및 히스톤 탈아세틸화효소 저해 화합물의 스크리닝 방법 |
AU2003243151A1 (en) | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
WO2004090113A2 (fr) * | 2003-03-31 | 2004-10-21 | Seattle Genetics, Inc. | L53, antigene associe au cancer du poumon et ses utilisations |
US20080260742A1 (en) * | 2004-04-09 | 2008-10-23 | Takeda Pharmaceutical Company Limited | Preventives/Remedies for Cancer |
CA2585267A1 (fr) * | 2004-10-29 | 2007-02-08 | University Of Rochester | Vecteurs de bacteriophage modifie et utilisation de ceux-ci |
NZ591825A (en) * | 2005-07-26 | 2012-10-26 | Cms Peptides Patent Holding Company Ltd | Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue |
EP2961419A4 (fr) * | 2013-02-26 | 2016-12-21 | Rongfu Wang | Compositions de phf20 et jmjd3 et méthodes d'utilisation pour l'immunothérapie anticancéreuse |
US11795201B2 (en) | 2017-04-14 | 2023-10-24 | University Of Massachusetts | Brown fat-selective adipokines |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5831052A (en) * | 1997-05-07 | 1998-11-03 | Incyte Pharmaceuticals, Inc. | New human translocation associated protein |
EP1130094A3 (fr) * | 1999-07-08 | 2001-11-21 | Helix Research Institute | Amorces pour la synthèse de cADN de pleine longueur et leur utilisation |
EP1254221A2 (fr) * | 2000-01-06 | 2002-11-06 | Protegene Inc. | Proteines humaines a domaines hydrophobes et adn codant ces proteines |
-
2001
- 2001-02-26 EP EP01912764A patent/EP1276751A4/fr not_active Withdrawn
- 2001-02-26 CA CA002401505A patent/CA2401505A1/fr not_active Abandoned
- 2001-02-26 AU AU2001241511A patent/AU2001241511A1/en not_active Abandoned
- 2001-02-26 WO PCT/US2001/004926 patent/WO2001064834A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1276751A2 (fr) | 2003-01-22 |
WO2001064834A2 (fr) | 2001-09-07 |
EP1276751A4 (fr) | 2005-04-06 |
CA2401505A1 (fr) | 2001-09-07 |
AU2001241511A1 (en) | 2001-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001064835A8 (fr) | Nouveaux acides nucleiques et polypeptides | |
WO2001064834A8 (fr) | Nouveaux acides nucleiques et polypeptides | |
CY1118443T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
ATE469911T1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
NO20020348D0 (no) | Peptid acceptor ligeringsmetoder | |
DK1482040T3 (da) | NL3-TIE-receptortyrosinkinaseligandhomologer | |
WO2001075067A3 (fr) | Nouveaux acides nucleiques et polypeptides | |
WO2001057188A3 (fr) | Nouveaux acides nucleiques et polypeptides | |
WO2001057190A3 (fr) | Acides nucleiques et polypeptides | |
WO2001066689A3 (fr) | Nouveaux acides nucleiques et polypeptides | |
ATE541857T1 (de) | Optimierte fc-varianten und herstellungsverfahren dafür | |
ATE317441T1 (de) | Cathepsin-02-protease | |
ATE411082T1 (de) | Neue verwendung von kurzkettigen carbonsäuren | |
WO2001088088A3 (fr) | Nouveaux acides nucleiques et polypeptides | |
CY1109207T1 (el) | Διαδικασια εχινοκανδινης | |
WO2004087874A3 (fr) | Acides nucleiques et polypeptides | |
WO2002018424A3 (fr) | Nouveaux acides nucleiques et polypeptides | |
SE9801455D0 (sv) | New receptor | |
DK1157100T3 (da) | Oxaloacetathydrolase-defekte svampeværtsceller | |
TR200501541T2 (tr) | Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları | |
DE60139544D1 (de) | Veränderte, fluoreszierende proteine | |
ATE321853T1 (de) | Humanische pellino-polypeptide | |
WO2001079449A3 (fr) | Acides nucleiques et polypeptides nouveaux | |
BR9916460A (pt) | Produção de ácido ascórbico usando levedura | |
BR0202969B1 (pt) | bomba de combustìvel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
D17 | Declaration under article 17(2)a | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2401505 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001912764 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001912764 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10220335 Country of ref document: US |
|
NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001912764 Country of ref document: EP |